Graded
The US health department published a draft policy under which it would not act against pharmacies that make BPC-157 on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.
PL

Terms of service

These terms apply to this site, operated by the publisher named in the imprint. The binding version is the Polish one.

1. Service

The site provides free access to information about scientific evidence and regulation, and an optional e-mail summary. You need a standard web browser and, for the newsletter, an e-mail address.

2. Nature of the content

Content is for information and education. It does not promote or encourage the use or purchase of any substance and is not medical advice, diagnosis or treatment. It does not replace consultation with a doctor or pharmacist. We sell no products.

3. Rules of use

The site is intended for adults. You may not provide unlawful content, and you may not disrupt the site.

4. Accuracy and liability

We take care to keep information accurate and show when each entry was checked, but science and law change. To the extent permitted by law, we are not liable for decisions made on the basis of the content.

5. Newsletter

The newsletter requires a separate consent, which you can withdraw at any time through the link in each message.

6. Complaints

Send complaints to the address in the imprint. We reply within 14 days.

7. Final provisions

Polish law applies, without limiting mandatory consumer protection. We may change these terms for important reasons and will publish the date of the change here.

Effective date: 2 November 2026